Sleep and the cholinergic rem sleep induction test in patients with primary alcoholism.
Sleep disturbances of alcoholics while actively drinking and at the beginning of, and during, abstinence were frequently reported. Recently, Gillin et al. (1994) showed that a high "REM sleep pressure" at the time of admission to a 1-month inpatient alcohol treatment program predicted the relapse in nondepressed patients with primary alcoholism at 3 months following hospital discharge. We investigated 24 patients with primary alcoholism after 2-3 weeks abstinence in the sleep laboratory; in 15 of these patients the cholinergic REM sleep induction test (CRIT) with 10 mg galanthamine was performed additionally. In comparison with an age- and sex-matched healthy control group, patients had a heightened "REM sleep pressure" including shortened REM latency and increased REM density. A decrease of serotonergic neurotransmission is proposed as being the neurochemical mechanism to explain the results in alcoholic subjects. Follow-up investigations will clarify whether the sleep abnormalities in alcoholism are state- or trait-markers and whether they are suitable to predict the relapse risk.
Gann
H J
HJ
Department of Psychiatry and Psychotherapy, University of Freiburg, Freiburg, D-79104, Germany.
Faulmann
A
A
Kiemen
A
A
Klein
T
T
Ebert
D
D
Backhaus
J
J
Hornyak
M
M
Voderholzer
U
U
Hohagen
F
F
Berger
M
M
Riemann
D
D
D000328:Adult; D000437:Alcoholism / Q000150:complications / Q000503:physiopathology*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004311:Double-Blind Method; D005260:Female; D005702:Galantamine / Q000494:pharmacology*; D006801:Humans; D008297:Male; D017286:Polysomnography; D012893:Sleep Wake Disorders / Q000209:etiology / Q000503:physiopathology*; D012895:Sleep, REM / Q000187:drug effects*
D002800:Cholinesterase Inhibitors; D005702:Galantamine